机译:Dicer1和Foxl2突变状态与卵巢塞托利莱西迪格细胞肿瘤中的临床病理特征相关
Univ British Columbia Dept Mol Oncol Vancouver BC Canada;
Univ British Columbia Dept Mol Oncol Vancouver BC Canada;
Tubingen Univ Hosp Dept Womens Hlth Tubingen Germany;
Univ British Columbia Dept Mol Oncol Vancouver BC Canada;
Univ British Columbia Dept Mol Oncol Vancouver BC Canada;
Tubingen Univ Hosp Dept Womens Hlth Tubingen Germany;
Univ British Columbia Dept Mol Oncol Vancouver BC Canada;
Univ British Columbia Dept Mol Oncol Vancouver BC Canada;
Univ British Columbia Dept Gynecol &
Obstet Div Gynecol Oncol Vancouver BC Canada;
Inst Pathol Viersen Germany;
Univ British Columbia Dept Pathol &
Lab Med Vancouver BC Canada;
Univ British Columbia Dept Mol Oncol Vancouver BC Canada;
Univ British Columbia Dept Mol Oncol Vancouver BC Canada;
Inst Pathol Med Campus Bodensee Roentgenstr 2 D-88048 Friedrichshafen Germany;
Sertoli-Leydig cell tumor; DICER1; FOXL2; heterologous elements; retiform pattern; molecular classifier;
机译:Dicer1和Foxl2突变状态与卵巢塞托利莱西迪格细胞肿瘤中的临床病理特征相关
机译:Dicer1突变对卵巢Sertoli-Leydig细胞瘤中MicroRNA表达谱的影响:东南亚队列的分析
机译:Dicer1 RNase IIIB结构域突变在卵巢Sertoli-Leydig细胞肿瘤中的致癌作用
机译:髋臼腺癌30例初级淋巴瘤患者的临床病理特征
机译:卵巢肿瘤内肿瘤异质性的发展:癌症干细胞在疾病进展中的作用。
机译:DICER1 RNase IIIb域突变在卵巢Sertoli-Leydig细胞肿瘤中的致癌作用。
机译:DICER1 RNase IIIb结构域突变在卵巢支抗 - 睾丸间质细胞肿瘤中的致癌作用